Catholic University, Ružomberok, Slovakia.
Euro Surveill. 2013 Mar 21;18(12):20432.
In the European Union (EU) 72,334 tuberculosis (TB) cases were notified in 2011, of which 16,116 (22%) had extrapulmonary tuberculosis (EPTB). The percentage of TB cases with EPTB ranged from 4% to 48% in the reporting countries. This difference might be explained by differences in risk factors for EPTB or challenges in diagnosis. To assess the practices in diagnosis of EPTB we asked European Union/European Economic Area (EU/EEA) countries to participate in a report describing the diagnostic procedures and challenges in diagnosing EPTB. Eleven EU Member States participated and reports showed that in the majority EPTB is diagnosed by a pulmonologist, sometimes in collaboration with the doctor who is specialised in the organ where the symptoms presented. In most countries a medical history and examination is followed by invasive procedures, puncture or biopsy, to collect material for confirmation of the disease (by culture/histology/cytology). Some countries also use the tuberculin skin test or an interferon-gamma-release-assay. A wide variety of radiological tests may be used. Countries that reported challenges in the diagnosis of EPTB reported that EPTB is often not considered because it is a rare disease and most medical professionals will not have experience in diagnosing EPTB. The fact that EPTB can present with a variety of symptoms that may mimic symptoms of other pathologies does pose a further challenge in diagnosis. In addition, obtaining an appropriate sample for confirmation of EPTB was frequently mentioned as a challenge. In summary, diagnosis of EPTB poses challenges due to the diversity of symptoms with which EPTB may present, the low level of suspicion of clinicians, and due to the difficulty in obtaining an adequate sample for confirmation.
2011 年,欧盟(EU)报告了 72334 例结核病(TB)病例,其中 16116 例(22%)为肺外结核病(EPTB)。报告国家的 EPTB 占结核病病例的百分比从 4%到 48%不等。这种差异可能是由于 EPTB 的危险因素不同或诊断方面的挑战造成的。为了评估 EPTB 的诊断实践,我们要求欧盟/欧洲经济区(EU/EEA)国家参与报告,描述 EPTB 的诊断程序和挑战。11 个欧盟成员国参与了报告,报告显示,在大多数国家,EPTB 由肺病专家诊断,有时与专门治疗出现症状的器官的医生合作进行诊断。在大多数国家,病史和检查后会进行侵袭性程序,如穿刺或活检,以收集用于确认疾病的标本(通过培养/组织学/细胞学)。一些国家还使用结核菌素皮肤试验或干扰素 - γ 释放试验。可能会使用各种影像学检查。报告在 EPTB 诊断方面存在挑战的国家报告说,EPTB 通常不被考虑,因为它是一种罕见疾病,大多数医疗专业人员在诊断 EPTB 方面没有经验。EPTB 可能表现出多种症状,这些症状可能与其他病理的症状相似,这确实对诊断构成了进一步的挑战。此外,获得用于确认 EPTB 的适当样本也经常被认为是一个挑战。总之,EPTB 的诊断因 EPTB 可能出现的症状多样性、临床医生的低怀疑水平以及难以获得用于确认的适当样本而带来挑战。